BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 11815495)

  • 1. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
    Rohlfing CL; Wiedmeyer HM; Little RR; England JD; Tennill A; Goldstein DE
    Diabetes Care; 2002 Feb; 25(2):275-8. PubMed ID: 11815495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.
    Kilpatrick ES; Rigby AS; Atkin SL
    Clin Chem; 2007 May; 53(5):897-901. PubMed ID: 17384010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
    Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
    Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.
    Brennan AL; Gyi KM; Wood DM; Hodson ME; Geddes DM; Baker EH
    J Cyst Fibros; 2006 Jan; 5(1):27-31. PubMed ID: 16202666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?
    Hillman N; Herranz L; Grande C; Vaquero PM; Pallardo LF
    Diabet Med; 2004 May; 21(5):468-70. PubMed ID: 15089792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
    Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
    Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual divergence in the relationship between the values of plasma glucose and hemoglobin A1c in type 2 diabetes.
    Fukudome M; Nakazaki M; Fukushige E; Koriyama N; Ikeda Y; Kato K; Kimura T; Tei C
    Intern Med; 2009; 48(5):273-9. PubMed ID: 19252347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is HbA(1c) affected by glycemic instability?
    Derr R; Garrett E; Stacy GA; Saudek CD
    Diabetes Care; 2003 Oct; 26(10):2728-33. PubMed ID: 14514571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.
    Bonora E; Calcaterra F; Lombardi S; Bonfante N; Formentini G; Bonadonna RC; Muggeo M
    Diabetes Care; 2001 Dec; 24(12):2023-9. PubMed ID: 11723077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
    ; Wilson DM; Xing D; Beck RW; Block J; Bode B; Fox LA; Hirsch I; Kollman C; Laffel L; Ruedy KJ; Steffes M; Tamborlane WV
    Diabetes Care; 2011 Mar; 34(3):540-4. PubMed ID: 21266647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.
    Avignon A; Radauceanu A; Monnier L
    Diabetes Care; 1997 Dec; 20(12):1822-6. PubMed ID: 9405900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
    McCarter RJ; Hempe JM; Gomez R; Chalew SA
    Diabetes Care; 2004 Jun; 27(6):1259-64. PubMed ID: 15161772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between glycated haemoglobin levels and mean glucose levels over time.
    Nathan DM; Turgeon H; Regan S
    Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
    Boot M; Volkening LK; Butler DA; Laffel LM
    Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.
    Nathan DM; McGee P; Steffes MW; Lachin JM;
    Diabetes; 2014 Jan; 63(1):282-90. PubMed ID: 23990364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
    Pickup JC; Freeman SC; Sutton AJ
    BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.